Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

Summary

The primary purpose of the study is to investigate the safety and efficacy of KP-1461 given every 12 hours for 124 days to HIV+ patients who have failed multiple antiretroviral regimens.

Timeline

Start

2007-07

Primary completion

2008-09

Completion

2009-06

Outcome

Outcome not reported

Stopped: “Corroboration of supporting in vitro data \- Data successfully corroborated 2009”

Drugs

Indications